0001408474-16-000002.txt : 20160120 0001408474-16-000002.hdr.sgml : 20160120 20160120114038 ACCESSION NUMBER: 0001408474-16-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160120 FILED AS OF DATE: 20160120 DATE AS OF CHANGE: 20160120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC CENTRAL INDEX KEY: 0001105533 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562110007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 BUSINESS PHONE: 9192876300 MAIL ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 FORMER COMPANY: FORMER CONFORMED NAME: MERIX BIOSCIENCE INC DATE OF NAME CHANGE: 20000207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALLEN LEE F MD PhD CENTRAL INDEX KEY: 0001408474 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35443 FILM NUMBER: 161350202 MAIL ADDRESS: STREET 1: C/O AMAG PHARMACEUTICALS, INC. STREET 2: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2016-01-20 0 0001105533 ARGOS THERAPEUTICS INC ARGS 0001408474 ALLEN LEE F MD PhD C/O ARGOS THERAPEUTICS, INC. 4233 TECHNOLOGY DRIVE DURHAM NC 27704 0 1 0 0 Chief Medical Officer Stock Option (right to buy) 2.16 2016-01-19 4 A 0 300000 0 A 2026-01-18 Common Stock 300000 300000 D This option was granted on January 19, 2016 and vests as to 25% of the shares underlying this option on January 18, 2017, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning January 18, 2017. Lori R. Harrelson, attorney-in-fact 2016-01-20